Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DBV Technologies

DBVT
Current price
0.74 USD +0.014 USD (+1.85%)
Last closed 0.7 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 158 561 408 USD
Yield for 12 month -43.24 %
Week
Month
Year
DBVT
21.11.2021 - 28.11.2021

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and eosinophilic esophagitis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. Address: 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120

Analytics

WallStreet Target Price

4.97 USD

P/E ratio

Dividend Yield

Current Year

+5 225 627 USD

Last Year

+6 214 142 USD

Current Quarter

+2 612 814 USD

Last Quarter

Current Year

+5 225 627 USD

Last Year

+6 214 142 USD

Current Quarter

+2 612 814 USD

Last Quarter

Key Figures DBVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -88 716 000 USD
Operating Margin TTM -770.24 %
PE Ratio
Return On Assets TTM -29.27 %
PEG Ratio
Return On Equity TTM -56.61 %
Wall Street Target Price 4.97 USD
Revenue TTM 5 549 000 USD
Book Value 1.5 USD
Revenue Per Share TTM 0.03 USD
Dividend Share
Quarterly Revenue Growth YOY 14.4 %
Dividend Yield
Gross Profit TTM 4 844 000 USD
Earnings Share -0.55 USD
Diluted Eps TTM -0.55 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DBVT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DBVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DBVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 28.5748
Enterprise Value EBITDA -0.0039
Price Book MRQ 0.9275

Financials DBVT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators DBVT

For 52 weeks

0.65 USD 2.37 USD
50 Day MA 1.06 USD
Shares Short Prior Month 174 585
200 Day MA 1.52 USD
Short Ratio 1.09
Shares Short 353 985
Short Percent 1.74 %